Atrovent Nasal en es it fr

Atrovent Nasal Brand names, Atrovent Nasal Analogs

Atrovent Nasal Brand Names Mixture

  • Combivent Inhalation Aerosol (Ipratropium Bromide + Salbutamol Sulfate)
  • Combivent Inhalation Solution (Ipratropium Bromide + Salbutamol Sulfate)
  • Duovent Udv (Fenoterol Hydrobromide + Ipratropium Bromide)
  • Ratio-Ipra Sal Udv (Ipratropium Bromide + Salbutamol Sulfate)

Atrovent Nasal Chemical_Formula


Atrovent Nasal RX_link

Atrovent Nasal fda sheet

Atrovent_Nasal FDA

Atrovent Nasal msds (material safety sheet)

Atrovent Nasal Synthesis Reference

K. Zeile et al.,U.S. Pat. 3,505,337 (1970)

Atrovent Nasal Molecular Weight

332.457 g/mol

Atrovent Nasal Melting Point


Atrovent Nasal H2O Solubility

Freely soluble

Atrovent Nasal State


Atrovent Nasal LogP

No information avaliable

Atrovent Nasal Dosage Forms

Aerosol (with propellants); Liquid; Metered-dose (aerosol); Metered-dose (pump); Solution

Atrovent Nasal Indication

For maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Atrovent Nasal Pharmacology

Ipratropium bromide, a synthetic ammonium compound structurally similar to atropine, is used as a bronchodilator in the management of cholinergic-mediated bronchospasm associated with chronic obstructive pulmonary disease and in the treatment of rhinorrhea associated with the common cold or with allergic or nonallergic seasonal rhinitis.

Atrovent Nasal Absorption

Inhalation (local)-minimal; Nasal-rapid and minimal

Atrovent Nasal side effects and Toxicity

LD50=1001mg/kg (orally in mice)

Atrovent Nasal Patient Information

Atrovent Nasal Organisms Affected

Humans and other mammals